SE0200312D0 - Novel composition - Google Patents

Novel composition

Info

Publication number
SE0200312D0
SE0200312D0 SE0200312A SE0200312A SE0200312D0 SE 0200312 D0 SE0200312 D0 SE 0200312D0 SE 0200312 A SE0200312 A SE 0200312A SE 0200312 A SE0200312 A SE 0200312A SE 0200312 D0 SE0200312 D0 SE 0200312D0
Authority
SE
Sweden
Prior art keywords
novel composition
formoterol
budesonide
formulation
treatment
Prior art date
Application number
SE0200312A
Other languages
English (en)
Swedish (sv)
Inventor
Maria Marlow
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20286853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0200312(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0200312A priority Critical patent/SE0200312D0/xx
Publication of SE0200312D0 publication Critical patent/SE0200312D0/xx
Priority to DK08166881.6T priority patent/DK2036549T3/da
Priority to RU2004122921/15A priority patent/RU2301673C2/ru
Priority to SI200331563T priority patent/SI1474117T1/sl
Priority to EP03703575A priority patent/EP1474117B1/en
Priority to CA2474479A priority patent/CA2474479C/en
Priority to PCT/SE2003/000156 priority patent/WO2003063842A1/en
Priority to UA20040806416A priority patent/UA79445C2/uk
Priority to KR1020047011787A priority patent/KR100947168B1/ko
Priority to AT08166881T priority patent/ATE463241T1/de
Priority to EP08166881A priority patent/EP2036549B1/en
Priority to PT03703575T priority patent/PT1474117E/pt
Priority to PT08166881T priority patent/PT2036549E/pt
Priority to KR1020097024298A priority patent/KR20090125857A/ko
Priority to BR0307193-6A priority patent/BR0307193A/pt
Priority to AU2003206289A priority patent/AU2003206289B2/en
Priority to DE60332067T priority patent/DE60332067D1/de
Priority to SI200331805T priority patent/SI2036549T1/sl
Priority to ES08166881T priority patent/ES2342509T3/es
Priority to US10/502,685 priority patent/US7759328B2/en
Priority to DK03703575T priority patent/DK1474117T3/da
Priority to JP2003563536A priority patent/JP2005521663A/ja
Priority to CNB038031221A priority patent/CN1287774C/zh
Priority to ES03703575T priority patent/ES2321180T3/es
Priority to PL372118A priority patent/PL211836B1/pl
Priority to NZ534452A priority patent/NZ534452A/en
Priority to DE60326320T priority patent/DE60326320D1/de
Priority to AT03703575T priority patent/ATE423552T1/de
Priority to IS7360A priority patent/IS7360A/is
Priority to IL163160A priority patent/IL163160A/en
Priority to CO04071996A priority patent/CO5611098A2/es
Priority to MXPA04007295A priority patent/MXPA04007295A/es
Priority to ZA2004/06086A priority patent/ZA200406086B/en
Priority to NO20043458A priority patent/NO337006B1/no
Priority to CY20091100471T priority patent/CY1109030T1/el
Priority to HK09105851.8A priority patent/HK1126684A1/xx
Priority to JP2010041992A priority patent/JP5259636B2/ja
Priority to US12/790,196 priority patent/US8143239B2/en
Priority to CY20101100546T priority patent/CY1110081T1/el
Priority to US13/411,939 priority patent/US8575137B2/en
Priority to IS9028A priority patent/IS2960B/is
Priority to US14/057,548 priority patent/US20140286878A1/en
Priority to US14/635,550 priority patent/US20160022703A1/en
Priority to US15/427,425 priority patent/US10166247B2/en
Priority to US16/108,368 priority patent/US20190216828A1/en
Priority to US16/832,590 priority patent/US11311558B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Networks Using Active Elements (AREA)
  • Pyrane Compounds (AREA)
SE0200312A 2002-02-01 2002-02-01 Novel composition SE0200312D0 (sv)

Priority Applications (46)

Application Number Priority Date Filing Date Title
SE0200312A SE0200312D0 (sv) 2002-02-01 2002-02-01 Novel composition
DE60326320T DE60326320D1 (de) 2002-02-01 2003-01-29 Zusammensetzung zur inhalation
RU2004122921/15A RU2301673C2 (ru) 2002-02-01 2003-01-29 Композиция для ингаляции
JP2003563536A JP2005521663A (ja) 2002-02-01 2003-01-29 吸入用組成物
PL372118A PL211836B1 (pl) 2002-02-01 2003-01-29 Kompozycja farmaceutyczna do stosowania w leczeniu lub profilaktyce zaburzeń układu oddechowego i jej zastosowanie
SI200331563T SI1474117T1 (sl) 2002-02-01 2003-01-29 Sestavek za inhalacijo
ES03703575T ES2321180T3 (es) 2002-02-01 2003-01-29 Composicion para inhalacion.
CA2474479A CA2474479C (en) 2002-02-01 2003-01-29 Composition for inhalation
PCT/SE2003/000156 WO2003063842A1 (en) 2002-02-01 2003-01-29 Composition for inhalation
UA20040806416A UA79445C2 (en) 2002-02-01 2003-01-29 Stable formulation for inhalation comprising formoterol and budesonide
KR1020047011787A KR100947168B1 (ko) 2002-02-01 2003-01-29 흡입용 조성물
AT08166881T ATE463241T1 (de) 2002-02-01 2003-01-29 Neuartige zusammensetzung
EP08166881A EP2036549B1 (en) 2002-02-01 2003-01-29 Novel Composition
PT03703575T PT1474117E (pt) 2002-02-01 2003-01-29 Composição para inalação
PT08166881T PT2036549E (pt) 2002-02-01 2003-01-29 Nova composição
KR1020097024298A KR20090125857A (ko) 2002-02-01 2003-01-29 흡입용 조성물
BR0307193-6A BR0307193A (pt) 2002-02-01 2003-01-29 Composição para inalação
AU2003206289A AU2003206289B2 (en) 2002-02-01 2003-01-29 Composition for inhalation
DE60332067T DE60332067D1 (de) 2002-02-01 2003-01-29 Neuartige Zusammensetzung
SI200331805T SI2036549T1 (sl) 2002-02-01 2003-01-29 Novi sestavek
NZ534452A NZ534452A (en) 2002-02-01 2003-01-29 Pharmaceutical composition containing formoterol and budesonide used in inhalers
US10/502,685 US7759328B2 (en) 2002-02-01 2003-01-29 Composition for inhalation
DK03703575T DK1474117T3 (da) 2002-02-01 2003-01-29 Sammensætning af inhalation
DK08166881.6T DK2036549T3 (da) 2002-02-01 2003-01-29 Ny sammensætning
CNB038031221A CN1287774C (zh) 2002-02-01 2003-01-29 用于吸入的组合物
EP03703575A EP1474117B1 (en) 2002-02-01 2003-01-29 Composition for inhalation
AT03703575T ATE423552T1 (de) 2002-02-01 2003-01-29 Zusammensetzung zur inhalation
ES08166881T ES2342509T3 (es) 2002-02-01 2003-01-29 Nueva composicion.
IS7360A IS7360A (is) 2002-02-01 2004-07-21 Efnablanda til innöndunar
IL163160A IL163160A (en) 2002-02-01 2004-07-22 Pharmaceuticals containing Formavertrol, Budsunida, 227hf 'pvp and peg for the treatment or relief of respiratory disorders
CO04071996A CO5611098A2 (es) 2002-02-01 2004-07-27 Composicion para inhalacion
MXPA04007295A MXPA04007295A (es) 2002-02-01 2004-07-28 Composicion para inhalacion.
ZA2004/06086A ZA200406086B (en) 2002-02-01 2004-07-29 Composition for inhalation
NO20043458A NO337006B1 (no) 2002-02-01 2004-08-19 Sammensetning for inhalering
CY20091100471T CY1109030T1 (el) 2002-02-01 2009-04-29 Συνθεση για εισπνοη
HK09105851.8A HK1126684A1 (en) 2002-02-01 2009-06-30 Novel composition
JP2010041992A JP5259636B2 (ja) 2002-02-01 2010-02-26 吸入用組成物
US12/790,196 US8143239B2 (en) 2002-02-01 2010-05-28 Composition for inhalation
CY20101100546T CY1110081T1 (el) 2002-02-01 2010-06-14 Νεα συνθεση
US13/411,939 US8575137B2 (en) 2002-02-01 2012-03-05 Composition for inhalation
IS9028A IS2960B (is) 2002-02-01 2013-04-16 Ný efnablanda
US14/057,548 US20140286878A1 (en) 2002-02-01 2013-10-18 Composition for inhalation
US14/635,550 US20160022703A1 (en) 2002-02-01 2015-03-02 Composition for Inhalation
US15/427,425 US10166247B2 (en) 2002-02-01 2017-02-08 Composition for inhalation
US16/108,368 US20190216828A1 (en) 2002-02-01 2018-08-22 Composition for Inhalation
US16/832,590 US11311558B2 (en) 2002-02-01 2020-03-27 Composition for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200312A SE0200312D0 (sv) 2002-02-01 2002-02-01 Novel composition

Publications (1)

Publication Number Publication Date
SE0200312D0 true SE0200312D0 (sv) 2002-02-01

Family

ID=20286853

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200312A SE0200312D0 (sv) 2002-02-01 2002-02-01 Novel composition

Country Status (28)

Country Link
US (8) US7759328B2 (no)
EP (2) EP1474117B1 (no)
JP (2) JP2005521663A (no)
KR (2) KR20090125857A (no)
CN (1) CN1287774C (no)
AT (2) ATE423552T1 (no)
AU (1) AU2003206289B2 (no)
BR (1) BR0307193A (no)
CA (1) CA2474479C (no)
CO (1) CO5611098A2 (no)
CY (2) CY1109030T1 (no)
DE (2) DE60326320D1 (no)
DK (2) DK1474117T3 (no)
ES (2) ES2342509T3 (no)
HK (1) HK1126684A1 (no)
IL (1) IL163160A (no)
IS (2) IS7360A (no)
MX (1) MXPA04007295A (no)
NO (1) NO337006B1 (no)
NZ (1) NZ534452A (no)
PL (1) PL211836B1 (no)
PT (2) PT2036549E (no)
RU (1) RU2301673C2 (no)
SE (1) SE0200312D0 (no)
SI (2) SI1474117T1 (no)
UA (1) UA79445C2 (no)
WO (1) WO2003063842A1 (no)
ZA (1) ZA200406086B (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US9084799B2 (en) 2005-02-11 2015-07-21 Pulmagen Therapeutics (Synergy) Limited Inhaled combination therapy
JP5579368B2 (ja) * 2005-02-11 2014-08-27 プルマゲン セラピューティクス （シナジー） リミテッド 慢性呼吸器疾患を治療するためのメチルキサンチン化合物とステロイドの組み合わせ
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20130160761A1 (en) * 2008-11-04 2013-06-27 Cipla Limited Pharmaceutical Aerosol Composition
NZ574666A (en) * 2009-02-05 2009-04-30 Nexus6 Ltd A medicament inhaler holder that uses optical means to count and display the number of doses used
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
WO2010133294A2 (de) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
UA107097C2 (en) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Dispenser
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US20130274232A1 (en) * 2010-07-16 2013-10-17 Cipla Limited Pharmaceutical Compositions
ES2628891T3 (es) * 2010-08-03 2017-08-04 Chiesi Farmaceutici S.P.A. Formulación farmacéutica que comprende un inhibidor de fosfodiesterasa
EP2618816A4 (en) * 2010-09-22 2014-10-29 Map Pharmaceuticals Ltd AEROSOL COMPOSITION FOR THE ADMINISTRATION OF MEDICAMENTS
US20120204871A1 (en) 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
US9241904B1 (en) 2011-08-19 2016-01-26 Intech Biopharm Ltd. Method for preparing metered dose sprayed inhaler for treating respiratory disease
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
US10195374B2 (en) 2014-05-07 2019-02-05 Boehringer Ingelheim International Gmbh Container, nebulizer and use
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
LT3928818T (lt) 2014-05-07 2023-03-27 Boehringer Ingelheim International Gmbh Purkštuvas ir talpa
US20170189329A1 (en) * 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
EP4101292A1 (en) 2015-04-10 2022-12-14 Eden Green Global Technologies Limited Apparatus for hydroponic cultivation
BR112018011266B1 (pt) 2015-12-04 2023-11-21 Mexichem Fluor S.A. De C.V. Composição farmacêutica, recipiente vedado, e, métodos para tratar um paciente que sofre ou é propenso a sofrer de um distúrbio respiratório e para estabilizar uma composição farmacêutica
CN106581010B (zh) * 2016-12-28 2019-03-05 四川普锐特医药科技有限责任公司 一种气溶胶制剂及定量吸入气雾剂
CA3073195A1 (en) 2017-08-15 2019-02-21 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
JP7470646B2 (ja) 2018-06-14 2024-04-18 アストラゼネカ・ユーケイ・リミテッド コルチコステロイド医薬組成物を用いて喘息の症状を治療および予防するための方法
JP7402631B2 (ja) 2018-08-27 2023-12-21 帝人株式会社 極細炭素繊維混合物、その製造方法、及び炭素系導電助剤
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
CN112137957B (zh) 2019-06-26 2022-07-29 长风药业股份有限公司 一种药用吸入气雾剂及其制备方法
CN112972384B (zh) * 2019-12-02 2022-03-18 长风药业股份有限公司 一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法
CN117357485A (zh) * 2023-11-01 2024-01-09 山东京卫制药有限公司 一种改良的可吸入的载体颗粒及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
NZ244439A (en) * 1991-09-25 1994-01-26 Fisons Plc Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
AU673660C (en) 1991-12-18 2002-07-25 Astrazeneca Ab New combination of formoterol and budesonide
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
ES2178015T3 (es) 1996-11-11 2002-12-16 Sepracor Inc Procedimiento de preparacion de isomeros de formoterol opticamente puros.
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
ES2234266T3 (es) 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv) 1999-03-09 1999-03-09 Astra Ab Novel combination
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009584D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
GB0016876D0 (en) 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition

Also Published As

Publication number Publication date
DK1474117T3 (da) 2009-05-25
US20160022703A1 (en) 2016-01-28
JP2010132695A (ja) 2010-06-17
DE60332067D1 (de) 2010-05-20
US8575137B2 (en) 2013-11-05
US20190216828A1 (en) 2019-07-18
EP1474117B1 (en) 2009-02-25
ZA200406086B (en) 2006-01-25
RU2004122921A (ru) 2005-06-10
ATE463241T1 (de) 2010-04-15
EP1474117A1 (en) 2004-11-10
ES2321180T3 (es) 2009-06-03
KR20040081757A (ko) 2004-09-22
KR100947168B1 (ko) 2010-03-12
AU2003206289B2 (en) 2007-09-06
IL163160A (en) 2013-12-31
SI2036549T1 (sl) 2010-07-30
PL372118A1 (en) 2005-07-11
US7759328B2 (en) 2010-07-20
JP2005521663A (ja) 2005-07-21
DE60326320D1 (de) 2009-04-09
US11311558B2 (en) 2022-04-26
CN1625392A (zh) 2005-06-08
US20140286878A1 (en) 2014-09-25
IS9028A (is) 2013-04-16
US20210069215A1 (en) 2021-03-11
CN1287774C (zh) 2006-12-06
CA2474479C (en) 2011-04-05
NO20043458L (no) 2004-08-19
US20120216802A1 (en) 2012-08-30
WO2003063842A1 (en) 2003-08-07
ATE423552T1 (de) 2009-03-15
ES2342509T3 (es) 2010-07-07
HK1126684A1 (en) 2009-09-11
DK2036549T3 (da) 2010-07-12
US20050089478A1 (en) 2005-04-28
US20170368078A1 (en) 2017-12-28
SI1474117T1 (sl) 2009-06-30
US8143239B2 (en) 2012-03-27
UA79445C2 (en) 2007-06-25
CO5611098A2 (es) 2006-02-28
IS2960B (is) 2017-02-15
WO2003063842A9 (en) 2004-04-22
RU2301673C2 (ru) 2007-06-27
US10166247B2 (en) 2019-01-01
JP5259636B2 (ja) 2013-08-07
CA2474479A1 (en) 2003-08-07
EP2036549A1 (en) 2009-03-18
PT1474117E (pt) 2009-04-24
CY1110081T1 (el) 2015-01-14
BR0307193A (pt) 2004-11-03
NZ534452A (en) 2006-01-27
MXPA04007295A (es) 2004-10-29
PL211836B1 (pl) 2012-06-29
PT2036549E (pt) 2010-06-22
IS7360A (is) 2004-07-21
EP2036549B1 (en) 2010-04-07
US20100275913A1 (en) 2010-11-04
KR20090125857A (ko) 2009-12-07
CY1109030T1 (el) 2014-07-02
NO337006B1 (no) 2015-12-21

Similar Documents

Publication Publication Date Title
DE60332067D1 (de) Neuartige Zusammensetzung
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
CY2014019I2 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
DE602004029367D1 (de) Therapeutische und/oder präventive zusammsentzung für periodontale erkrankungen
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
SG148194A1 (en) Compositions for the treatment of affections of the oral cavity and upper respiratory tract
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
EA200500328A1 (ru) Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства
DK1670482T4 (da) Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
ATE501719T1 (de) Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
EE200400074A (et) Koostised ning nende kasutamine proliferatiivsetehaiguste raviks
DE60212349D1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines pharmazeutischen mittels zur prävention und behandlung von sexuellen störungen
EP1677745A4 (en) NITRON COMPOUND PRODRUGS AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF HUMAN DISEASES
SE9901273D0 (sv) Novel compounds
ITMI20021455A0 (it) Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico
IL165653A (en) Compounds, compositions comprising them and use thereof for the manufacture of medicaments for the treatment of inflammatory diseases, disorders and conditions